ClassID:

95260

C07D405/12 - page 10 - CPC Classification

Classification description:

Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#2701
20180044296
2018-02-15

Histone demethylase inhibitors

#2702
20180044293
2018-02-15

Asymmetric ureas and medical uses thereof

#2703
20180044290
2018-02-15

Urea derivative or pharmacologically acceptable salt thereof

#2704
20180044288
2018-02-15

Kinase inhibitors

#2705
20180044287
2018-02-15

Sulfonylureas and related compounds and use of same

#2706
20180044282
2018-02-15

ALPHA-CINNAMIDE COMPOUNDS AND COMPOSITIONS AS HDAC8 INHIBITORS

#2707
20180043009
2018-02-15

Lipids and compositions for the delivery of therapeutics

#2708
20180042935
2018-02-15

Theramutein modulators

#2709
20180042908
2018-02-15

Phenyl derivative

#2710
20180037587
2018-02-08

Substituted Tricyclics and Method of Use

#2711
20180037576
2018-02-08

Substituted pyrimidine compounds as phosphatidylinositol 3-kinase delta inhibitor and use thereof

#2712
20180037566
2018-02-08

Therapeutic compounds and uses thereof

#2713
20180037554
2018-02-08

Aminoquinazoline compounds as Aantagonist

#2714
20180037553
2018-02-08

Inhibitors of tryptophan-2,3-dioxygenase or indoleamine-2,3-dioxygenase

#2715
20180036308
2018-02-08

Compounds

#2716
20180036300
2018-02-08

Substituted N-bicyclo-2-aryl-quinolin-4-carboxamides and use thereof

#2717
20180030078
2018-02-01

Quinoline derivative for use in the treatment and prevention of viral infections

#2718
20180030075
2018-02-01

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

#2719
20180030038
2018-02-01

Polymorphic Forms of Afatinib Dimaleate

#2720
20180030034
2018-02-01

Quinazolines as potassium ion channel inhibitors

#2721
20180030019
2018-02-01

Substituted benzofuran compounds for the treatment of hepatitis C

#2722
20180030017
2018-02-01

Benzofurans substituted with primary benzamide as HCV inhibitors

#2723
20180030016
2018-02-01

Benzofuran compounds for the treatment of hepatitis C

#2724
20180029996
2018-02-01

Bicyclic quinazolinone derivatives

#2725
20180029988
2018-02-01

Compounds for inhibiting c-Myc/Max/DNA complex formation

#2726
20180029985
2018-02-01

Pharmaceutically active compounds

#2727
20180029984
2018-02-01

PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING

#2728
20180028511
2018-02-01

S1P modulating agents

#2729
20180026188
2018-01-25

Spirobifluorene derivative-based materials for electronic devices

#2730
20180024136
2018-01-25

Development of ABCG2-Sensitive Fluorescent Probe For Isolation of ABCG2low Neural Stem/Progenitor Cells

#2731
20180022998
2018-01-25

Liquid crystal compound having benzopyran skeleton, liquid crystal composition, and liquid crystal display device

#2732
20180022767
2018-01-25

Compounds for treatment of complement mediated disorders

#2733
20180022766
2018-01-25

Ether compounds for treatment of complement mediated disorders

#2734
20180022723
2018-01-25

Compounds for the treatment of hepatitis C

#2735
20180022722
2018-01-25

Compounds for stabilizing ryanodine receptors from aberrant levels of calcium release

#2736
20180022716
2018-01-25

Polymerizable compound and optical isomer

#2737
20180022704
2018-01-25

Process for the preparation of histamine H3 receptor modulators

#2738
20180022701
2018-01-25

4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof

#2739
20180021346
2018-01-25

GLP-1 receptor modulators

#2740
20180021345
2018-01-25

Autotaxin inhibitors

#2741
20180016282
2018-01-18

INHIBITORS OF HISTONE DEACETYLASE

#2742
20180016262
2018-01-18

5-hydroxytryptamine receptor 7 activity modulators and their method of use

#2743
20180016261
2018-01-18

5-hydroxytryptamine receptor 7 activity modulators and their method of use

#2744
20180016260
2018-01-18

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

#2745
20180016249
2018-01-18

Methods of Treating an Overweight or Obese Subject

#2746
20180016243
2018-01-18

HUMAN HELICASE DDX3 INHIBITORS AS THERAPEUTIC AGENTS

#2747
20180016239
2018-01-18

Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof

#2748
20180016236
2018-01-18

Pyridic ketone derivatives, method of preparing same, and pharmaceutical application thereof

#2749
20180016235
2018-01-18

Pyridone amides as modulators of sodium channels

#2750
20180016234
2018-01-18

Herbicidal phenylpyridines

#2751
20180009798
2018-01-11

Inhibitors of beta-hydroxylase for treatment of cancer

#2752
20180009792
2018-01-11

Chromenone inhibitors of monocarboxylate transporters

#2753
20180009791
2018-01-11

Crystalline form of a benzimidazole derivative and a preparation method thereof

#2754
20180009782
2018-01-11

Protein tyrosine kinase modulators and methods of use

#2755
20180009781
2018-01-11

Inhibitors of TrkA kinase

#2756
20180009754
2018-01-11

Anthelmintic compounds, compositions and method of using thereof

#2757
20180009735
2018-01-11

Therapeutic compounds and uses thereof

#2758
20180008613
2018-01-11

Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment

#2759
20180008574
2018-01-11

2-oxo-1,2-dihydrobenzo[cd]indole compound and use thereof

#2760
20180008561
2018-01-11

Compositions and methods for treating metabolic disorders

#2761
20180008554
2018-01-11

Immunomodulator compounds

#2762
20180003702
2018-01-04

T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds

#2763
20180002321
2018-01-04

Substituted mono- and polyazanaphthalene derivatives and their use

#2764
20180002320
2018-01-04

USE OF MACROCYCLIC PICOLINAMIDES AS FUNGICIDES

#2765
20180002319
2018-01-04

MACROCYCLIC PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY

#2766
20180002308
2018-01-04

Tricyclic spiro compound

#2767
20180002307
2018-01-04

PARTIALLY SATURATED TRICYCLIC COMPOUNDS AND METHODS OF MAKING AND USING SAME

#2768
20180002305
2018-01-04

PROCESS FOR PREPARING BENZOFURAN-2-CARBOXAMIDE DERIVATIVES

#2769
20180002296
2018-01-04

S-TRIAZOLYL ALPHA-MERCAPTO ACETANILIDES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE

#2770
20180002293
2018-01-04

5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis

#2771
20170373265
2017-12-28

Organic light emitting device

#2772
20170369483
2017-12-28

Aryl sulfonamides

#2773
20170369480
2017-12-28

Compounds, compositions, and methods for increasing CFTR activity

#2774
20170369479
2017-12-28

Cyclic compounds substituted by a condensed ring system

#2775
20170369462
2017-12-28

Modulation of Bacterial Quorum Sensing with Synthetic Ligands

#2776
20170369449
2017-12-28

Kinase inhibitors for the treatment of disease

#2777
20170369444
2017-12-28

INHIBITORS OF HISTONE DEMETHYLASES

#2778
20170369443
2017-12-28

Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof

#2779
20170368188
2017-12-28

Treatment or prophylaxis of proliferative conditions

#2780
20170368060
2017-12-28

Piperazine-substituted benzothiophenes for treatment of mental disorders

#2781
20170368017
2017-12-28

Antibacterial compounds

#2782
20170365788
2017-12-21

Amine compound and organic light emitting element comprising same

#2783
20170362579
2017-12-21

Conjugates for assays for oxycodone and oxymorphone

#2784
20170362260
2017-12-21

Neprilysin inhibitors

#2785
20170362211
2017-12-21

Small molecule inhibitors of fibrosis

#2786
20170362210
2017-12-21

ANTI-ESTROGENIC COMPOUNDS

#2787
20170362184
2017-12-21

PRO-SURVIVAL COMPOUNDS

#2788
20170360785
2017-12-21

Pyrimidine FGFR4 inhibitors

#2789
20170360764
2017-12-21

Use of EP4 receptor antagonists in the treatment of cartilage disease

#2790
20170360045
2017-12-21

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#2791
20170360041
2017-12-21

N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1H)-ylidene]-2,2,2- trifluoroacetamide for control of agricultural/horticultural pests

#2792
20170355712
2017-12-14

AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS

#2793
20170355692
2017-12-14

Ethyldiamine orexin receptor antagonists

#2794
20170355664
2017-12-14

Neprilysin inhibitors

#2795
20170354620
2017-12-14

Substituted pyridyl-cycloalkyl-carboxylic acids, compositions containing them and medical uses thereof

#2796
20170349607
2017-12-07

Compounds active towards bromodomains

#2797
20170349594
2017-12-07

Biaryl derivative as GPR120 agonist

#2798
20170349575
2017-12-07

Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the treatment of chemokine-mediated pathologies

#2799
20170349574
2017-12-07

Neprilysin inhibitors

#2800
20170349516
2017-12-07

Hydroxyl compounds and compositions for cholesterol management and related uses

#2801
20170342088
2017-11-30

ULK1 inhibitors and methods using same

#2802
20170342081
2017-11-30

Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonists

#2803
20170342074
2017-11-30

Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

#2804
20170342063
2017-11-30

Blockers of the growth hormone receptor in disease prevention and treatment

#2805
20170342062
2017-11-30

Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR γ (T))

#2806
20170342060
2017-11-30

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

#2807
20170342058
2017-11-30

Fumagillol heterocyclic compounds and methods of making and using same

#2808
20170342054
2017-11-30

COMPOUNDS AND METHODS OF USE THEREOF

#2809
20170342043
2017-11-30

Fumigillol compounds and methods of making and using same

#2810
20170340746
2017-11-30

Pegylated carfilzomib compounds

#2811
20170334934
2017-11-23

Macrocyclic picolinamides as fungicides

#2812
20170334889
2017-11-23

Compounds and methods for activating the apoptotic arm of the unfolded protein response

#2813
20170334861
2017-11-23

Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof

#2814
20170334853
2017-11-23

Mixed disulfide conjugates of thienopyridine compounds and uses thereof

#2815
20170333433
2017-11-23

Quinazoline derivatives substituted by aniline, preparation method and use thereof

#2816
20170327503
2017-11-16

Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

#2817
20170327493
2017-11-16

CXCR7 receptor modulators

#2818
20170326124
2017-11-16

Opioid receptor ligands and methods of using and making same

#2819
20170326084
2017-11-16

Imaging composition and uses thereof

#2820
20170324038
2017-11-09

Heterocyclic compounds for use in electronic devices

#2821
20170320895
2017-11-09

Neprilysin inhibitors

#2822
20170320883
2017-11-09

CARM1 inhibitors and uses thereof

#2823
20170320835
2017-11-09

HIV replication inhibiting pyrimidines

#2824
20170320834
2017-11-09

Triazabutadienes as cleavable cross-linkers

#2825
20170320828
2017-11-09

Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof

#2826
20170320827
2017-11-09

Inhibitors of histone demethylases

#2827
20170319578
2017-11-09

Compounds and their use as BACE inhibitors

#2828
20170319559
2017-11-09

COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR

#2829
20170317290
2017-11-02

ORGANIC ELECTRONIC DEVICE AND DISPLAY APPARATUS USING COMPOSITION FOR ORGANIC ELECTRONIC DEVICE

#2830
20170313717
2017-11-02

GLP-1 receptor modulators

#2831
20170313714
2017-11-02

EGFR inhibitor, preparation method and use thereof

#2832
20170312292
2017-11-02

Therapeutic compounds and uses thereof

#2833
20170305925
2017-10-26

Process of synthesizing 3-(4-methylpiperazine-1-carbonyl)-7-oxabicyclo[2.2.1] heptane-2-carboxylic acid

#2834
20170305918
2017-10-26

Dual-warhead covalent inhibitors of FGFR-4

#2835
20170305890
2017-10-26

METHODS OF TREATING CANCER

#2836
20170305889
2017-10-26

METHODS OF TREATING CANCER

#2837
20170305887
2017-10-26

Anti-endothelial lipase compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases

#2838
20170305864
2017-10-26

Heterocyclic compounds as pesticides

#2839
20170304305
2017-10-26

QUINAZOLINE DERIVATIVES SUBSTITUTED BY ANILINE, PREPARATION METHOD AND USE THEREOF

#2840
20170298085
2017-10-19

Carbamate, ester, and ketone compounds for treatment of complement mediated disorders

#2841
20170298084
2017-10-19

Amide compounds for treatment of complement mediated disorders

#2842
20170298082
2017-10-19

Glycosidase inhibitors

#2843
20170298075
2017-10-19

Tetrahydroisoquinoline derived PRMT5-inhibitors

#2844
20170298074
2017-10-19

Compounds as rearranged during transfection (RET) inhibitors

#2845
20170298058
2017-10-19

HETEROCYCLIC RING AND CARBOCYCLIC DERIVATIVE

#2846
20170298045
2017-10-19

Therapeutically active compounds and their methods of use

#2847
20170298037
2017-10-19

5-hydroxytryptamine receptor 7 activity modulators and their method of use

#2848
20170298027
2017-10-19

Pyrimidines as sodium channel blockers

#2849
20170298025
2017-10-19

Histone demethylase inhibitors

#2850
20170298022
2017-10-19

Diamino-Pyridine, Pyrimidine, and Pyridazine Modulators of the Histamine H4 Receptor

#2851
20170298016
2017-10-19

Pyrrolic amide compound and preparation method and application thereof

#2852
20170295792
2017-10-19

Use of picolinamide compounds as fungicides

#2853
20170291917
2017-10-12

Kinase inhibitors

#2854
20170291892
2017-10-12

Substituted oxopyridine derivatives

#2855
20170290830
2017-10-12

Small molecule regulators of steroid receptor coactivators and methods of use thereof

#2856
20170283442
2017-10-05

Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules

#2857
20170283440
2017-10-05

CARM1 INHIBITORS AND USES THEREOF

#2858
20170283429
2017-10-05

Compounds for the treatment of paramyxovirus viral infections

#2859
20170283407
2017-10-05

Tetrahydroisoquinoline derived PRMT5-inhibitors

#2860
20170283400
2017-10-05

ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF

#2861
20170283399
2017-10-05

Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carboxamide

#2862
20170283389
2017-10-05

Synthesis of isoflavanes and intermediates thereof

#2863
20170281626
2017-10-05

PYRIMIDINEDIONE COMPOUNDS

#2864
20170275301
2017-09-28

Benzenesulfonyl-asymmetric ureas and medical uses thereof

#2865
20170275289
2017-09-28

Therapeutic compounds and uses thereof

#2866
20170275279
2017-09-28

Specific inhibitors of methionyl-tRNA synthetase

#2867
20170275274
2017-09-28

Isoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2

#2868
20170275273
2017-09-28

Estrogen receptor modulators and uses thereof

#2869
20170273981
2017-09-28

Hydantoin derivatives useful as Kv3 inhibitors

#2870
20170273951
2017-09-28

Anesthetic compounds and related methods of use

#2871
20170273306
2017-09-28

MACROCYCLIC PICOLINAMIDES AS FUNGICIDES

#2872
20170273303
2017-09-28

MACROCYCLIC PICOLINAMIDES AS FUNGICIDES

#2873
20170267670
2017-09-21

Piperazine derivatives for treating disorders

#2874
20170267664
2017-09-21

Quinazolin-THF-amines as PDE1 inhibitors

#2875
20170267655
2017-09-21

Process for preparing benzofuran-2-carboxamide derivatives

#2876
20170267650
2017-09-21

Sodium channel blockers

#2877
20170267647
2017-09-21

Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith

#2878
20170267643
2017-09-21

Pyrazolyl guanidine FF-ATPase inhibitors and therapeutic uses thereof

#2879
20170267642
2017-09-21

Arginine methyltransferase inhibitors and uses thereof

#2880
20170266160
2017-09-21

Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C

#2881
20170260207
2017-09-14

Biaryl amide compounds as kinase inhibitors

#2882
20170260206
2017-09-14

Androgen receptor modulating compounds

#2883
20170260200
2017-09-14

Compounds and compositions as kinase inhibitors

#2884
20170260195
2017-09-14

Sulfoximine substituted quinazolines for pharmaceutical compositions

#2885
20170260174
2017-09-14

Benzene, Pyridine, and Pyridazine Derivatives

#2886
20170260143
2017-09-14

Compounds

#2887
20170253594
2017-09-07

Heteroaryl compounds for kinase inhibition

#2888
20170253591
2017-09-07

Heterocyclic compound

#2889
20170253581
2017-09-07

SUBSTITUTED HETEROCYCLES AS c-MYC TARGETING AGENTS

#2890
20170253563
2017-09-07

Kinase inhibitors

#2891
20170253562
2017-09-07

Nampt Inhibitors

#2892
20170252349
2017-09-07

Aryl-or heteroaryl-substituted benzene compounds

#2893
20170247388
2017-08-31

Inhibitors of IRAK4 activity

#2894
20170247376
2017-08-31

Methods and compositions for inhibition of Ras

#2895
20170247360
2017-08-31

HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF

#2896
20170247357
2017-08-31

Pyridine derivatives as soft rock inhibitors

#2897
20170247356
2017-08-31

PROCESSES FOR THE PREPARATION OF EMPAGLIFLOZIN

#2898
20170247340
2017-08-31

Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof

#2899
20170247336
2017-08-31

SUBSTITUTED PYRIMIDINES AS INHIBITORS OF HIF PROLYL HYDROXYLASE

#2900
20170247326
2017-08-31

Substituted Pyrrolidine Carboxamide Compounds

#2901
20170246167
2017-08-31

2,4-pyrimidinediamine compounds and their uses

#2902
20170240533
2017-08-24

Crystalline form of afatinib dimaleate

#2903
20170240525
2017-08-24

Methods and compounds for restoring mutant p53 function

#2904
20170240519
2017-08-24

Benzofuran analogue as NS4B inhibitor

#2905
20170239245
2017-08-24

Pyrimidine derivatives for the treatment of viral infections

#2906
20170233391
2017-08-17

Fused tricyclic urea compounds as raf kinase and/or raf kinase dimer inhibitors

#2907
20170233377
2017-08-17

Heterocyclic compounds as NaV channel inhibitors and uses thereof

#2908
20170233365
2017-08-17

Cyclooctenes for bioorthogonol reactions

#2909
20170233352
2017-08-17

HSP70 modulators and methods for making and using the same

#2910
20170233345
2017-08-17

SUBSTITUTED QUINOLINE-4-CARBOXAMIDES AND USE THEREOF

#2911
20170233340
2017-08-17

Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof

#2912
20170231999
2017-08-17

IDO inhibitors

#2913
20170226154
2017-08-10

PPAR agonists and methods of use thereof

#2914
20170226137
2017-08-10

Substituted piperidine compound and use thereof

#2915
20170226131
2017-08-10

Inhibitors of PI3K-delta and methods of their use and manufacture

#2916
20170226124
2017-08-10

PHTHALAZINONE DERIVATIVES

#2917
20170226115
2017-08-10

Selective inhibitors of constitutive androstane receptor

#2918
20170226099
2017-08-10

Quinazoline derivative

#2919
20170226096
2017-08-10

Benzamide derivatives as modulators of the follicle stimulating hormone

#2920
20170226093
2017-08-10

Cyanoquinoline derivatives

#2921
20170226080
2017-08-10

Pyrrolidinone derivatives as MetAP-2 inhibitors

#2922
20170226065
2017-08-10

Potent dual BRD4-kinase inhibitors as cancer therapeutics

#2923
20170224653
2017-08-10

TLR-independent small molecule adjuvants

#2924
20170218353
2017-08-03

Ligand-directed covalent modification of protein

#2925
20170217981
2017-08-03

Inhibitors of IRAK4 activity

#2926
20170217963
2017-08-03

Sphinogosine-1-phosphate receptor modulators for treatment of cardiopulmonary disorders

#2927
20170217961
2017-08-03

Pyrimidine-2,4-diamine derivatives for treatment of cancer

#2928
20170217949
2017-08-03

4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group

#2929
20170217939
2017-08-03

Crystalline forms of vilazodone hydrochloride and vilazodone free base

#2930
20170217909
2017-08-03

Bicyclic arylcarboxylic acid amides and their use as herbicides

#2931
20170217905
2017-08-03

Aminopyrimidine derivatives for use as modulators of kinase activity

#2932
20170216300
2017-08-03

EZH2 inhibitors for treating lymphoma

#2933
20170216279
2017-08-03

Methods for treating depressive symptoms

#2934
20170216259
2017-08-03

Compositions and methods for targeting receptors expressed in the gut

#2935
20170213985
2017-07-27

Organic optoelectronic device and display device

#2936
20170210991
2017-07-27

COMPOUND HAVING A DIFLUOROCYCLOHEXANE RING, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE

#2937
20170210759
2017-07-27

Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies

#2938
20170210749
2017-07-27

THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE

#2939
20170210730
2017-07-27

Heteroaryl substituted pyridyl compounds useful as kinase modulators

#2940
20170210729
2017-07-27

ERK inhibitors and uses thereof

#2941
20170210713
2017-07-27

Pyrimidine carboxamides as sodium channel blockers

#2942
20170210700
2017-07-27

3-aryl propiolonitrile compounds for thiol labeling

#2943
20170204078
2017-07-20

Apigenin analogs, compositions, and methods related thereto

#2944
20170197983
2017-07-13

Heterocyclic compounds having cholesterol 24-hydroxylase activity

#2945
20170197981
2017-07-13

Inhibitors of bacterial DNA gyrase with efficacy against gram-negative bacteria

#2946
20170197978
2017-07-13

Heteroaryl substituted compounds as RORγ inhibitors

#2947
20170197976
2017-07-13

MTH1 inhibitors for treatment of cancer

#2948
20170197973
2017-07-13

Immunoregulatory agents

#2949
20170197971
2017-07-13

3-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

#2950
20170197962
2017-07-13

Heteroaryl compounds for kinase inhibition

#2951
20170197922
2017-07-13

Benzimidazol-2-amines as MIDH1 inhibitors

#2952
20170197919
2017-07-13

3-(Carboxyethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

#2953
20170190715
2017-07-06

Pyridine derivative

#2954
20170190704
2017-07-06

Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease

#2955
20170190669
2017-07-06

Pyrazole compounds and methods of making and using same

#2956
20170189410
2017-07-06

Amino compounds for treatment of complement mediated disorders

#2957
20170189399
2017-07-06

Neprilysin inhibitors

#2958
20170186952
2017-06-29

Compound and organic light-emitting device including the same

#2959
20170183324
2017-06-29

MACROCYCLIC PICOLINAMIDES COMPOUNDS WITH FUNGICIDAL ACTIVITY

#2960
20170179400
2017-06-22

Carbazole-based compound and organic light-emitting device including the same

#2961
20170174718
2017-06-22

Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists

#2962
20170174713
2017-06-22

Tank-binding kinase inhibitor compounds

#2963
20170174689
2017-06-22

Substituted indole Mcl-1 inhibitors

#2964
20170174671
2017-06-22

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

#2965
20170174669
2017-06-22

POCHOXIME CONJUGATES USEFUL FOR THE TREATMENT OF HSP90 RELATED PATHOLOGIES

#2966
20170174668
2017-06-22

Sulfoximine substituted quinazolines for pharmaceutical compositions

#2967
20170174652
2017-06-22

Inhibitors of the fibroblast growth factor receptor

#2968
20170174646
2017-06-22

3-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereof

#2969
20170166578
2017-06-15

Antidiabetic substituted heteroaryl compounds

#2970
20170166577
2017-06-15

Apelin receptor (APJ) agonists and uses thereof

#2971
20170166563
2017-06-15

2-amino-benzimidazole derivatives and their use as 5-lipoxygenase and/or prostaglandin E synthase inhibitors

#2972
20170166558
2017-06-15

O-GLCNAC TRANSFERASE (OGT) INHIBITORS AND USES THEREOF

#2973
20170166555
2017-06-15

FUNCTIONALISED AND SUBSTITUTED INDOLES AS ANTI-CANCER AGENTS

#2974
20170166554
2017-06-15

Beta-arrestin-biased cannabinoid CB1 receptor agonists and methods for making and using them

#2975
20170166548
2017-06-15

Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals

#2976
20170166533
2017-06-15

Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto

#2977
20170166524
2017-06-15

N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors

#2978
20170165263
2017-06-15

Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

#2979
20170165241
2017-06-15

Compositions and methods of modulating 15-PGDH activity

#2980
20170165209
2017-06-15

Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk

#2981
20170162790
2017-06-08

Aromatic amine derivatives and organic electroluminescent elements using same

#2982
20170159100
2017-06-08

Water-soluble activatable molecular probes, intermediates for the synthesis thereof and associated detection methods

#2983
20170159023
2017-06-08

Low-molecular-compound for improving production, maintenance and proliferation of pluripotent stem cells, composition comprising the same, and culture method

#2984
20170158727
2017-06-08

Hamamelitannin analogues and uses thereof

#2985
20170158709
2017-06-08

Bromodomain inhibitors

#2986
20170158704
2017-06-08

Pyrimidinone derivative having autotaxin-inhibitory activity

#2987
20170158702
2017-06-08

MULTIVALENT RAS BINDING COMPOUNDS

#2988
20170158692
2017-06-08

Compounds and methods for inhibiting fascin

#2989
20170158685
2017-06-08

Histone demethylase inhibitors

#2990
20170158684
2017-06-08

Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient

#2991
20170158681
2017-06-08

Histone demethylase inhibitors

#2992
20170158677
2017-06-08

Substituted indazole derivatives active as kinase inhibitors

#2993
20170158676
2017-06-08

Processes for producing cycloalkylcarboxamido-pyridine benzoic acids

#2994
20170158644
2017-06-08

2-amino-5-keto-pyrimidine derivatives and the use thereof for controlling undesired plant growth

#2995
20170158636
2017-06-08

FUNCTIONALISED AND SUBSTITUTED CARBAZOLES AS ANTI-CANCER AGENTS

#2996
20170158634
2017-06-08

CARBOXAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

#2997
20170157092
2017-06-08

Anti-depression compounds

#2998
20170152252
2017-06-01

TRPV1 vanilloid receptor antagonists with a bicyclic portion

#2999
20170152249
2017-06-01

Benzimidazole derivatives as kinase inhibitors

#3000
20170152234
2017-06-01

Compositions and methods for quadricyclane modification of biomolecules